文献速递其他结缔组织病

聚(ADP-核糖)聚合酶-1调控系统性硬化症中的成纤维细胞活化

Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2018-02-03

该研究探讨PARP-1在系统性硬化症(SSc)发病中的作用,发现SSc患者成纤维细胞中PARP-1表达降低且启动子高甲基化,PARP-1失活可增强TGFβ/Smad信号并加重实验性纤维化,提示PARP-1下调可能直接促进SSc成纤维细胞持续活化。

要点

  • SSc患者成纤维细胞中PARP-1表达降低,其启动子呈高甲基化。
  • PARP-1失活增强TGFβ/Smad信号、胶原释放及肌成纤维细胞分化。
  • PARP-1缺陷加重博来霉素诱导的小鼠皮肤纤维化。

核心结论

  • PARP-1在实验性皮肤纤维化中负向调控经典TGFβ信号。
  • SSc成纤维细胞中PARP-1下调可能直接导致TGFβ信号过度活跃及成纤维细胞持续活化。

研究设计与样本

  • 研究检测了SSc患者样本中PARP-1的表达,并在博来霉素诱导、拓扑异构酶诱导纤维化及Tsk-1小鼠中研究PARP-1失活的影响。

主要发现

  • SSc患者中PARP-1表达降低,尤其在成纤维细胞中;SSc成纤维细胞及TGFβ刺激的正常成纤维细胞中PARP-1启动子高甲基化。
  • 抑制DNA甲基转移酶(DNMTs)可降低启动子甲基化并重新激活PARP-1表达。
  • PARP-1失活促进磷酸化Smad3积累、增强Smad依赖转录并上调TGFβ/Smad靶基因表达。
  • 抑制PARP-1在体外增强TGFβ对胶原释放和肌成纤维细胞分化的作用,在体内加重实验性纤维化。
  • PARP-1缺陷导致对博来霉素更严重的纤维化反应,表现为真皮增厚、羟脯氨酸含量及肌成纤维细胞计数增加;抑制PARylation也加重Tsk-1小鼠及拓扑异构酶诱导纤维化小鼠的纤维化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The enzyme poly(ADP-ribose) polymerase-1 (PARP-1) transfers negatively charged ADP-ribose units to target proteins. This modification can have pronounced regulatory effects on target proteins. Recent studies showed that PARP-1 can poly(ADP-ribosyl)ate (PARylate) Smad proteins. However, the role of PARP-1 in the pathogenesis of systemic sclerosis (SSc) has not been investigated. METHODS: The expression of PARP-1 was determined by quantitative PCR and immunohistochemistry. DNA methylation was analysed by methylated DNA immunoprecipitation assays. Transforming growth factor-β (TGFβ) signalling was assessed using reporter assays, chromatin immunoprecipitation assays and target gene analysis. The effect of PARP-1 inactivation was investigated in bleomycin-induced and topoisomerase-induced fibrosis as well as in tight-skin-1 (Tsk-1) mice. RESULTS: The expression of PARP-1 was decreased in patients with SSc, particularly in fibroblasts. The promoter of PARP-1 was hypermethylated in SSc fibroblasts and in TGFβ-stimulated normal fibroblasts. Inhibition of DNA methyltransferases (DNMTs) reduced the promoter methylation and reactivated the expression of PARP-1. Inactivation of PARP-1 promoted accumulation of phosphorylated Smad3, enhanced Smad-dependent transcription and upregulated the expression of TGFβ/Smad target genes. Inhibition of PARP-1 enhanced the effect of TGFβ on collagen release and myofibroblast differentiation in vitro and exacerbated experimental fibrosis in vivo. PARP-1 deficiency induced a more severe fibrotic response to bleomycin with increased dermal thickening, hydroxyproline content and myofibroblast counts. Inhibition of PARylation also exacerbated fibrosis in Tsk-1 mice and in mice with topoisomerase-induced fibrosis. CONCLUSION: PARP-1 negatively regulates canonical TGFβ signalling in experimental skin fibrosis. The downregulation of PARP-1 in SSc fibroblasts may thus directly contribute to hyperactive TGFβ signalling and to persistent fibroblast activation in SSc.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Pötter S, Chen CW, et al. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis. Ann Rheum Dis. 2018. PMID: 29431122. doi:10.1136/annrheumdis-2017-212265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。